NELCAST.NSE

Nelcast Ltd.

In this briefing: The Beat Ideas: Shivalik Rasayan: Does USFDA Approval Marks a New Growth Chapter? The Climate Change Threat to Productivity ReNew Energy Global (RNW US): Decision Time On NBIO Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (29 Sep) Nelcast Ltd - Plant Visit Insights, Small-Cap Rising Star Gearing Up for Explosive Growth 1. The Beat Ideas: Shivalik Rasayan: Does USFDA Approval Marks a New Growth Chapter? Shivalik Rasayan, once focused on agrochemicals, has entered pharmaceuticals by acquiring Medicamen Biotech and securing USFDA approval for its new API plant at Dahej-II in 2024 . The company is transforming into a diversified chemicals and pharma player . Investments in R&D, larger agrochemical capacity, and regulated pharma access open pathways for higher-margin and sustainable growth. Despite past issues of underutilized plants, high costs, and delays , recent approvals and new facilities position Shivalik Rasayan for steadier performance and long-term growth if execution remains strong. 2.

In this briefing: Clarity Pharmaceuticals Ltd (CU6 AU): Strengthening Supply Chain for US Commercialization ECM Weekly (29 September 2025)- Zijin, Chery, CAREIT, Orion, Butong, Victory Giant, Northern Star Japan Morning Connection: US Higher Despite Upcoming Govt Shutdown and Potential Delayed Jobs Data Nelcast Ltd - Plant Visit Insights, Small-Cap Rising Star Gearing Up for Explosive Growth IPO Review: India's Youngest and Largest Player for Ethanol, Worth a Bet? 1. Clarity Pharmaceuticals Ltd (CU6 AU): Strengthening Supply Chain for US Commercialization Clarity Pharmaceuticals Ltd (CU6 AU) entered into a commercial manufacturing agreement with SpectronRx for64Cu-SAR-bisPSMA. SpectronRx is capable of producing up to 400K patient-ready doses of 64Cu-SAR-bisPSMA annually. Claritys Targeted Copper Theranostic products and clinical development programs will remain unaffected by the U.S. imposed 100% tariff on imports of branded pharmaceutical products. In July, Clarity completed A$203M institutional placement, resulting in a pro-forma cash balance of approximately A$288M.

In this briefing: Clarity Pharmaceuticals Ltd (CU6 AU): Strengthening Supply Chain for US Commercialization ECM Weekly (29 September 2025)- Zijin, Chery, CAREIT, Orion, Butong, Victory Giant, Northern Star Japan Morning Connection: US Higher Despite Upcoming Govt Shutdown and Potential Delayed Jobs Data Nelcast Ltd - Plant Visit Insights, Small-Cap Rising Star Gearing Up for Explosive Growth IPO Review: India's Youngest and Largest Player for Ethanol, Worth a Bet? 1. Clarity Pharmaceuticals Ltd (CU6 AU): Strengthening Supply Chain for US Commercialization Clarity Pharmaceuticals Ltd (CU6 AU) entered into a commercial manufacturing agreement with SpectronRx for64Cu-SAR-bisPSMA. SpectronRx is capable of producing up to 400K patient-ready doses of 64Cu-SAR-bisPSMA annually. Claritys Targeted Copper Theranostic products and clinical development programs will remain unaffected by the U.S. imposed 100% tariff on imports of branded pharmaceutical products. In July, Clarity completed A$203M institutional placement, resulting in a pro-forma cash balance of approximately A$288M.

In this briefing: ECM Weekly (29 September 2025)- Zijin, Chery, CAREIT, Orion, Butong, Victory Giant, Northern Star Japan Morning Connection: US Higher Despite Upcoming Govt Shutdown and Potential Delayed Jobs Data Nelcast Ltd - Plant Visit Insights, Small-Cap Rising Star Gearing Up for Explosive Growth IPO Review: India's Youngest and Largest Player for Ethanol, Worth a Bet? Integral Corp (5842 JP) Tekscend IPO Crystallizes Value; Discount Persists Without Payouts 1. ECM Weekly (29 September 2025)- Zijin, Chery, CAREIT, Orion, Butong, Victory Giant, Northern Star Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week. On the IPO front, this week saw a few good listings across the region while the spotlight will be on Zijin Gold (2259 HK) in the coming week. On the placements front, it was a relatively quiter week, as compared to some of the more recent weekly flows. 2. Japan Morning Connection: US Higher Despite Upcoming Govt Shutdown and Potential Delayed Jobs Data US eyeing rules for tech companies to buy 1:1 domestic made chips vs imported.

In this briefing: ECM Weekly (29 September 2025)- Zijin, Chery, CAREIT, Orion, Butong, Victory Giant, Northern Star Japan Morning Connection: US Higher Despite Upcoming Govt Shutdown and Potential Delayed Jobs Data Nelcast Ltd - Plant Visit Insights, Small-Cap Rising Star Gearing Up for Explosive Growth IPO Review: India's Youngest and Largest Player for Ethanol, Worth a Bet? Integral Corp (5842 JP) Tekscend IPO Crystallizes Value; Discount Persists Without Payouts 1. ECM Weekly (29 September 2025)- Zijin, Chery, CAREIT, Orion, Butong, Victory Giant, Northern Star Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week. On the IPO front, this week saw a few good listings across the region while the spotlight will be on Zijin Gold (2259 HK) in the coming week. On the placements front, it was a relatively quiter week, as compared to some of the more recent weekly flows. 2. Japan Morning Connection: US Higher Despite Upcoming Govt Shutdown and Potential Delayed Jobs Data US eyeing rules for tech companies to buy 1:1 domestic made chips vs imported.

In this briefing: Japan Morning Connection: US Higher Despite Upcoming Govt Shutdown and Potential Delayed Jobs Data Nelcast Ltd - Plant Visit Insights, Small-Cap Rising Star Gearing Up for Explosive Growth IPO Review: India's Youngest and Largest Player for Ethanol, Worth a Bet? Integral Corp (5842 JP) Tekscend IPO Crystallizes Value; Discount Persists Without Payouts TOPPAN Holdings IPO Premium Priced In, Core Execution the Next Test 1. Japan Morning Connection: US Higher Despite Upcoming Govt Shutdown and Potential Delayed Jobs Data US eyeing rules for tech companies to buy 1:1 domestic made chips vs imported. Globalfoundries and Intelbothstrong. Boeing strong after Turkey order, although the big catalyst will be China orders after a 5-year hiatus. Musk comments that tesla was busy scaling the Optimus may help Harmonic Drive catch big after woeful perf last week. 2. Nelcast Ltd - Plant Visit Insights, Small-Cap Rising Star Gearing Up for Explosive Growth We visited two manufacturing plants of Nelcast Ltd (NELC IN) located in the southern part of India.

In this briefing: Japan Morning Connection: US Higher Despite Upcoming Govt Shutdown and Potential Delayed Jobs Data Nelcast Ltd - Plant Visit Insights, Small-Cap Rising Star Gearing Up for Explosive Growth IPO Review: India's Youngest and Largest Player for Ethanol, Worth a Bet? Integral Corp (5842 JP) Tekscend IPO Crystallizes Value; Discount Persists Without Payouts TOPPAN Holdings IPO Premium Priced In, Core Execution the Next Test 1. Japan Morning Connection: US Higher Despite Upcoming Govt Shutdown and Potential Delayed Jobs Data US eyeing rules for tech companies to buy 1:1 domestic made chips vs imported. Globalfoundries and Intelbothstrong. Boeing strong after Turkey order, although the big catalyst will be China orders after a 5-year hiatus. Musk comments that tesla was busy scaling the Optimus may help Harmonic Drive catch big after woeful perf last week. 2. Nelcast Ltd - Plant Visit Insights, Small-Cap Rising Star Gearing Up for Explosive Growth We visited two manufacturing plants of Nelcast Ltd (NELC IN) located in the southern part of India.

In this briefing: The Climate Change Threat to Productivity ReNew Energy Global (RNW US): Decision Time On NBIO Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (29 Sep) Nelcast Ltd - Plant Visit Insights, Small-Cap Rising Star Gearing Up for Explosive Growth IPO Review: India's Youngest and Largest Player for Ethanol, Worth a Bet? 1. The Climate Change Threat to Productivity The key question for investors is the likely trajectory of U.S. total factor productivity in the next decade. Our review shows that while AI adoption and deployment is a tailwind, stagnant population growth and the effects of climate change are headwinds. We conclude that, at best, factor productivity will be no better than trend. At worst, it will flatten and show little or no growth. 2. ReNew Energy Global (RNW US): Decision Time On NBIO Back on the 10th December 2024, ReNew Energy Global (RNW US) , an Indian renewable energy play, announced a non-binding Offer of US$7.07/share, by way of a Scheme. The bidding consortium, comprising (mainly) pre-IPO investors CPP, ADIA, Abu Dhabi Future Energy, and founder Sumant Sinha, collectively holding 64%.

In this briefing: The Climate Change Threat to Productivity ReNew Energy Global (RNW US): Decision Time On NBIO Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (29 Sep) Nelcast Ltd - Plant Visit Insights, Small-Cap Rising Star Gearing Up for Explosive Growth IPO Review: India's Youngest and Largest Player for Ethanol, Worth a Bet? 1. The Climate Change Threat to Productivity The key question for investors is the likely trajectory of U.S. total factor productivity in the next decade. Our review shows that while AI adoption and deployment is a tailwind, stagnant population growth and the effects of climate change are headwinds. We conclude that, at best, factor productivity will be no better than trend. At worst, it will flatten and show little or no growth. 2. ReNew Energy Global (RNW US): Decision Time On NBIO Back on the 10th December 2024, ReNew Energy Global (RNW US) , an Indian renewable energy play, announced a non-binding Offer of US$7.07/share, by way of a Scheme. The bidding consortium, comprising (mainly) pre-IPO investors CPP, ADIA, Abu Dhabi Future Energy, and founder Sumant Sinha, collectively holding 64%.